Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice

Adenosine modulates sleep via A(1) and A(2A) receptors. As the A(1) receptor influences Ca(V)2.1 channel functioning via G-protein inhibition, there is a possible role of the Ca(V)2.1 channel in sleep regulation. To this end we investigated transgenic Cacna1a R192Q mutant mice that express mutant Ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sleep (New York, N.Y.) N.Y.), 2013-01, Vol.36 (1), p.127-136
Hauptverfasser: Deboer, Tom, van Diepen, Hester C, Ferrari, Michel D, Van den Maagdenberg, Arn M J M, Meijer, Johanna H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 136
container_issue 1
container_start_page 127
container_title Sleep (New York, N.Y.)
container_volume 36
creator Deboer, Tom
van Diepen, Hester C
Ferrari, Michel D
Van den Maagdenberg, Arn M J M
Meijer, Johanna H
description Adenosine modulates sleep via A(1) and A(2A) receptors. As the A(1) receptor influences Ca(V)2.1 channel functioning via G-protein inhibition, there is a possible role of the Ca(V)2.1 channel in sleep regulation. To this end we investigated transgenic Cacna1a R192Q mutant mice that express mutant Ca(V)2.1 channels that are less susceptible to inhibition by G-proteins. We hypothesized that Cacna1a R192Q mice could show reduced susceptibility to adenosine, which may result in a sleep phenotype characterized by decreased sleep. R192Q mutant and littermate wild-type mice were subjected to a 6-h sleep deprivation, treatment with caffeine (a non-specific adenosine receptor antagonist which induces waking), or cyclopentyladenosine (CPA, an A(1) receptor specific agonist which induces sleep). Under baseline conditions, Cacna1a R192Q mice showed more waking with longer waking episodes in the dark period and less non-rapid eye movement (NREM) sleep, but equal amounts of REM sleep compared to wild-type. After treatment with caffeine R192Q mice initiated sleep 30 min earlier than wild-type, whereas after CPA treatment, R192Q mice woke up 260 min earlier than wild-type. Both results indicate that Cacna1a R192Q mice are less susceptible to adenosinergic input, which may explain the larger amount of waking under undisturbed baseline conditions. We here show that adenosinergic sleep induction, and responses to caffeine and CPA, are modified in the R192Q mutant in a manner consistent with decreased susceptibility to inhibition by adenosine. The data suggest that the A(1) receptor modulates sleep via the Ca(V)2.1 channel.
doi_str_mv 10.5665/sleep.2316
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3524534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>23288979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-91b6b50b5477fb8269d0a42d2297fa99aa9db943a4c0d543844ddc0af3275aad3</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbK1e_AGyZyF1P5PsRZDiFxTEoudlsrupK8mmZJNK_71pq0VPwzDvPDM8CF1SMpVpKm9i5dxqyjhNj9CYSkkSRYk6RmNCU5rklMgROovxkwy9UPwUjRhnea4yNUbzhbO9cRbvIBiCxVXzhcG60EQfXLv0BkcXou_82ncb7AM2YAJQwAuq2Cuu-w5Ch2tv3Dk6KaGK7uKnTtD7w_3b7CmZvzw-z-7mieFZ3g3fFWkhSSFFlpVFzlJlCQhmGVNZCUoBKFsowUEYYqXguRDWGgIlZ5kEsHyCbvfcVV_UzhoXuhYqvWp9De1GN-D1_0nwH3rZrDWXTEguBsD1HmDaJsbWlYddSvTWqd7p0FunQ_jq77VD9Fci_wZ6Y3RC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Deboer, Tom ; van Diepen, Hester C ; Ferrari, Michel D ; Van den Maagdenberg, Arn M J M ; Meijer, Johanna H</creator><creatorcontrib>Deboer, Tom ; van Diepen, Hester C ; Ferrari, Michel D ; Van den Maagdenberg, Arn M J M ; Meijer, Johanna H</creatorcontrib><description>Adenosine modulates sleep via A(1) and A(2A) receptors. As the A(1) receptor influences Ca(V)2.1 channel functioning via G-protein inhibition, there is a possible role of the Ca(V)2.1 channel in sleep regulation. To this end we investigated transgenic Cacna1a R192Q mutant mice that express mutant Ca(V)2.1 channels that are less susceptible to inhibition by G-proteins. We hypothesized that Cacna1a R192Q mice could show reduced susceptibility to adenosine, which may result in a sleep phenotype characterized by decreased sleep. R192Q mutant and littermate wild-type mice were subjected to a 6-h sleep deprivation, treatment with caffeine (a non-specific adenosine receptor antagonist which induces waking), or cyclopentyladenosine (CPA, an A(1) receptor specific agonist which induces sleep). Under baseline conditions, Cacna1a R192Q mice showed more waking with longer waking episodes in the dark period and less non-rapid eye movement (NREM) sleep, but equal amounts of REM sleep compared to wild-type. After treatment with caffeine R192Q mice initiated sleep 30 min earlier than wild-type, whereas after CPA treatment, R192Q mice woke up 260 min earlier than wild-type. Both results indicate that Cacna1a R192Q mice are less susceptible to adenosinergic input, which may explain the larger amount of waking under undisturbed baseline conditions. We here show that adenosinergic sleep induction, and responses to caffeine and CPA, are modified in the R192Q mutant in a manner consistent with decreased susceptibility to inhibition by adenosine. The data suggest that the A(1) receptor modulates sleep via the Ca(V)2.1 channel.</description><identifier>ISSN: 0161-8105</identifier><identifier>EISSN: 1550-9109</identifier><identifier>DOI: 10.5665/sleep.2316</identifier><identifier>PMID: 23288979</identifier><language>eng</language><publisher>United States: Associated Professional Sleep Societies, LLC</publisher><subject>Adenosine - analogs &amp; derivatives ; Adenosine - metabolism ; Adenosine - pharmacology ; Analysis of Variance ; Animals ; Caffeine ; Central Nervous System Stimulants ; Cross-Over Studies ; Disease Models, Animal ; Electroencephalography - methods ; Electromyography - methods ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Purinergic P1 Receptor Agonists ; Receptors, Purinergic P1 - metabolism ; Sleep Deprivation - chemically induced ; Sleep Deprivation - diagnosis ; Sleep Deprivation - metabolism ; Sleep Stages - drug effects ; Sleep, REM - physiology ; Sodium Chloride - administration &amp; dosage</subject><ispartof>Sleep (New York, N.Y.), 2013-01, Vol.36 (1), p.127-136</ispartof><rights>2013 Associated Professional Sleep Societies, LLC. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-91b6b50b5477fb8269d0a42d2297fa99aa9db943a4c0d543844ddc0af3275aad3</citedby><cites>FETCH-LOGICAL-c378t-91b6b50b5477fb8269d0a42d2297fa99aa9db943a4c0d543844ddc0af3275aad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23288979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deboer, Tom</creatorcontrib><creatorcontrib>van Diepen, Hester C</creatorcontrib><creatorcontrib>Ferrari, Michel D</creatorcontrib><creatorcontrib>Van den Maagdenberg, Arn M J M</creatorcontrib><creatorcontrib>Meijer, Johanna H</creatorcontrib><title>Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice</title><title>Sleep (New York, N.Y.)</title><addtitle>Sleep</addtitle><description>Adenosine modulates sleep via A(1) and A(2A) receptors. As the A(1) receptor influences Ca(V)2.1 channel functioning via G-protein inhibition, there is a possible role of the Ca(V)2.1 channel in sleep regulation. To this end we investigated transgenic Cacna1a R192Q mutant mice that express mutant Ca(V)2.1 channels that are less susceptible to inhibition by G-proteins. We hypothesized that Cacna1a R192Q mice could show reduced susceptibility to adenosine, which may result in a sleep phenotype characterized by decreased sleep. R192Q mutant and littermate wild-type mice were subjected to a 6-h sleep deprivation, treatment with caffeine (a non-specific adenosine receptor antagonist which induces waking), or cyclopentyladenosine (CPA, an A(1) receptor specific agonist which induces sleep). Under baseline conditions, Cacna1a R192Q mice showed more waking with longer waking episodes in the dark period and less non-rapid eye movement (NREM) sleep, but equal amounts of REM sleep compared to wild-type. After treatment with caffeine R192Q mice initiated sleep 30 min earlier than wild-type, whereas after CPA treatment, R192Q mice woke up 260 min earlier than wild-type. Both results indicate that Cacna1a R192Q mice are less susceptible to adenosinergic input, which may explain the larger amount of waking under undisturbed baseline conditions. We here show that adenosinergic sleep induction, and responses to caffeine and CPA, are modified in the R192Q mutant in a manner consistent with decreased susceptibility to inhibition by adenosine. The data suggest that the A(1) receptor modulates sleep via the Ca(V)2.1 channel.</description><subject>Adenosine - analogs &amp; derivatives</subject><subject>Adenosine - metabolism</subject><subject>Adenosine - pharmacology</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Caffeine</subject><subject>Central Nervous System Stimulants</subject><subject>Cross-Over Studies</subject><subject>Disease Models, Animal</subject><subject>Electroencephalography - methods</subject><subject>Electromyography - methods</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Transgenic</subject><subject>Purinergic P1 Receptor Agonists</subject><subject>Receptors, Purinergic P1 - metabolism</subject><subject>Sleep Deprivation - chemically induced</subject><subject>Sleep Deprivation - diagnosis</subject><subject>Sleep Deprivation - metabolism</subject><subject>Sleep Stages - drug effects</subject><subject>Sleep, REM - physiology</subject><subject>Sodium Chloride - administration &amp; dosage</subject><issn>0161-8105</issn><issn>1550-9109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1Lw0AQhhdRbK1e_AGyZyF1P5PsRZDiFxTEoudlsrupK8mmZJNK_71pq0VPwzDvPDM8CF1SMpVpKm9i5dxqyjhNj9CYSkkSRYk6RmNCU5rklMgROovxkwy9UPwUjRhnea4yNUbzhbO9cRbvIBiCxVXzhcG60EQfXLv0BkcXou_82ncb7AM2YAJQwAuq2Cuu-w5Ch2tv3Dk6KaGK7uKnTtD7w_3b7CmZvzw-z-7mieFZ3g3fFWkhSSFFlpVFzlJlCQhmGVNZCUoBKFsowUEYYqXguRDWGgIlZ5kEsHyCbvfcVV_UzhoXuhYqvWp9De1GN-D1_0nwH3rZrDWXTEguBsD1HmDaJsbWlYddSvTWqd7p0FunQ_jq77VD9Fci_wZ6Y3RC</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Deboer, Tom</creator><creator>van Diepen, Hester C</creator><creator>Ferrari, Michel D</creator><creator>Van den Maagdenberg, Arn M J M</creator><creator>Meijer, Johanna H</creator><general>Associated Professional Sleep Societies, LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20130101</creationdate><title>Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice</title><author>Deboer, Tom ; van Diepen, Hester C ; Ferrari, Michel D ; Van den Maagdenberg, Arn M J M ; Meijer, Johanna H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-91b6b50b5477fb8269d0a42d2297fa99aa9db943a4c0d543844ddc0af3275aad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adenosine - analogs &amp; derivatives</topic><topic>Adenosine - metabolism</topic><topic>Adenosine - pharmacology</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Caffeine</topic><topic>Central Nervous System Stimulants</topic><topic>Cross-Over Studies</topic><topic>Disease Models, Animal</topic><topic>Electroencephalography - methods</topic><topic>Electromyography - methods</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Transgenic</topic><topic>Purinergic P1 Receptor Agonists</topic><topic>Receptors, Purinergic P1 - metabolism</topic><topic>Sleep Deprivation - chemically induced</topic><topic>Sleep Deprivation - diagnosis</topic><topic>Sleep Deprivation - metabolism</topic><topic>Sleep Stages - drug effects</topic><topic>Sleep, REM - physiology</topic><topic>Sodium Chloride - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deboer, Tom</creatorcontrib><creatorcontrib>van Diepen, Hester C</creatorcontrib><creatorcontrib>Ferrari, Michel D</creatorcontrib><creatorcontrib>Van den Maagdenberg, Arn M J M</creatorcontrib><creatorcontrib>Meijer, Johanna H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Sleep (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deboer, Tom</au><au>van Diepen, Hester C</au><au>Ferrari, Michel D</au><au>Van den Maagdenberg, Arn M J M</au><au>Meijer, Johanna H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice</atitle><jtitle>Sleep (New York, N.Y.)</jtitle><addtitle>Sleep</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>36</volume><issue>1</issue><spage>127</spage><epage>136</epage><pages>127-136</pages><issn>0161-8105</issn><eissn>1550-9109</eissn><abstract>Adenosine modulates sleep via A(1) and A(2A) receptors. As the A(1) receptor influences Ca(V)2.1 channel functioning via G-protein inhibition, there is a possible role of the Ca(V)2.1 channel in sleep regulation. To this end we investigated transgenic Cacna1a R192Q mutant mice that express mutant Ca(V)2.1 channels that are less susceptible to inhibition by G-proteins. We hypothesized that Cacna1a R192Q mice could show reduced susceptibility to adenosine, which may result in a sleep phenotype characterized by decreased sleep. R192Q mutant and littermate wild-type mice were subjected to a 6-h sleep deprivation, treatment with caffeine (a non-specific adenosine receptor antagonist which induces waking), or cyclopentyladenosine (CPA, an A(1) receptor specific agonist which induces sleep). Under baseline conditions, Cacna1a R192Q mice showed more waking with longer waking episodes in the dark period and less non-rapid eye movement (NREM) sleep, but equal amounts of REM sleep compared to wild-type. After treatment with caffeine R192Q mice initiated sleep 30 min earlier than wild-type, whereas after CPA treatment, R192Q mice woke up 260 min earlier than wild-type. Both results indicate that Cacna1a R192Q mice are less susceptible to adenosinergic input, which may explain the larger amount of waking under undisturbed baseline conditions. We here show that adenosinergic sleep induction, and responses to caffeine and CPA, are modified in the R192Q mutant in a manner consistent with decreased susceptibility to inhibition by adenosine. The data suggest that the A(1) receptor modulates sleep via the Ca(V)2.1 channel.</abstract><cop>United States</cop><pub>Associated Professional Sleep Societies, LLC</pub><pmid>23288979</pmid><doi>10.5665/sleep.2316</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0161-8105
ispartof Sleep (New York, N.Y.), 2013-01, Vol.36 (1), p.127-136
issn 0161-8105
1550-9109
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3524534
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adenosine - analogs & derivatives
Adenosine - metabolism
Adenosine - pharmacology
Analysis of Variance
Animals
Caffeine
Central Nervous System Stimulants
Cross-Over Studies
Disease Models, Animal
Electroencephalography - methods
Electromyography - methods
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Purinergic P1 Receptor Agonists
Receptors, Purinergic P1 - metabolism
Sleep Deprivation - chemically induced
Sleep Deprivation - diagnosis
Sleep Deprivation - metabolism
Sleep Stages - drug effects
Sleep, REM - physiology
Sodium Chloride - administration & dosage
title Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T08%3A52%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20sleep%20and%20low%20adenosinergic%20sensitivity%20in%20cacna1a%20R192Q%20mutant%20mice&rft.jtitle=Sleep%20(New%20York,%20N.Y.)&rft.au=Deboer,%20Tom&rft.date=2013-01-01&rft.volume=36&rft.issue=1&rft.spage=127&rft.epage=136&rft.pages=127-136&rft.issn=0161-8105&rft.eissn=1550-9109&rft_id=info:doi/10.5665/sleep.2316&rft_dat=%3Cpubmed_cross%3E23288979%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/23288979&rfr_iscdi=true